Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia

Category Broad synthesis / Guideline
JournalTherapeutic Goods Administration (TGA)
Year 2017
Loading references information
This document reflects the evidence supporting the use of medicinal cannabis in treating symptoms of MS
Epistemonikos ID: a299e8764fafcf9fbbb8eff09ba2338c2b02c891
First added on: Jun 06, 2018